BitTech, Inc.
BitTech OncoLogic Corp. (BTOL)
BitTech OncoLogic Corp. (BTOL®) was incorporated 4/25/00, as a majority owned subsidiary of BitTech, Inc. BTOL was formed to commercialize proprietary cancer technology developed by BitTech, Inc. BTOL provides cancer genetic tests and proprietary databases as well as screening technology for cancer therapeutic discovery. The long term goal of BTOL is development of cancer treatments for the prevention of cancer.
The BitTech OncoLogic Corp. home page can be accessed at:
Copyright © 2001, BitTech, Inc.